1. Cohn L, Edmunds LH. Cardiac Surgery in the Adult. 2nd ed. New York: McGraw-Hill; 2003:xxiv, 1573 pp.
2. St. Andre
AC, DelRossi A. Hemodynamic management of patients in the first 24 hours after cardiac surgery.
Crit Care Med. 2005;33(9):2082–2093.
3. London MJ, Moritz T, Henderson W, et al. Standard versus fiberoptic pulmonary artery catheterization for cardiac surgery in the Department of Veterans Affairs: a prospective, observational, multicenter analysis. Anesthesiology. 2002;96(4):860–870.
4. Polonen P, et al. A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg. 2000;90(5):1052–1059.
5. Boyd O, Grounds RM, Bennett ED. A randomized clinical trial of the effect of deliberate perioperative increase of
oxygen delivery on mortality in high-risk surgical patients.
JAMA. 1993;270(22):2699–2707.
6. Yu M, et al. Effect of maximizing
oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study.
Crit Care Med. 1993;21(6):830–838.
7. Gattinoni L, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 1995;333(16):1025–1032.
8. Ernest D, Belzberg AS, Dodek PM. Distribution of normal saline and 5%
albumin infusions in septic patients.
Crit Care Med. 1999;27(1):46–50.
9. Gallagher JD, et al. Effects of colloid or crystalloid administration on pulmonary extravascular water in the postoperative period after coronary artery bypass grafting. Anesth Analg. 1985;64(8):753–758.
10. Fremes SE, et al. Effects of postoperative hypertension and its treatment. J Thorac Cardiovasc Surg. 1983; 86(1):47–56.
11. Feneck RO, et al. Comparison of the hemodynamic effects of
milrinone with
dobutamine in patients after cardiac surgery.
J Cardiothorac Vasc Anesth. 2001;15(3):306–315.
12. Kantrowitz A, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA. 1968;203(2):113–118.
13. Samuels LE, et al. Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock: experience with the Abiomed BVS system. J Card Surg. 1999;14(4):288–293.
14. Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med. 2001;135(12): 1061–1073.
15. Rho RW. The management of atrial fibrillation after cardiac surgery. Heart. 2009;95(5):422–429.
16. Hein OV, et al. Three-year survival after four major post-cardiac operative complications. Crit Care Med. 2006;34(11):2729–2737.
17. Baggish AL, Sabatine MS.
Clopidogrel use in coronary artery disease.
Expert Rev Cardiovasc Ther. 2006;4(1): 7–15.
18. Gill R, et al. Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation. 2009;120(1):21–27.
19. Higgins TL. Safety issues regarding early extubation after coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 1995;9(5 suppl 1):24–29.
20. Akhtar MI, Hamid M. Success and failure of fast track extubation in cardiac surgery patients of tertiary care hospital: one year audit. J Pak Med Assoc. 2009;59(3): 154–156.
21. Wong DT, et al. Risk factors of delayed extubation, prolonged length of stay in the intensive care unit, and mortality in patients undergoing coronary artery bypass graft with fast-track cardiac anesthesia: a new cardiac risk score. Anesthesiology. 1999;91(4):936–944.
22. Puntillo K, Weiss SJ. Pain: its mediators and associated morbidity in critically ill cardiovascular surgical patients. Nurs Res. 1994;43(1):31–36.
23. Gust R, et al. Effect of patient-controlled analgesia on pulmonary complications after coronary artery bypass grafting. Crit Care Med. 1999;27(10):2218–2223.
24. Jensen L, Yang L. Risk factors for postoperative pulmonary complications in coronary artery bypass graft surgery patients. Eur J Cardiovasc Nurs. 2007;6(3):241–246.
25. Wynne R, Botti M. Postoperative pulmonary dysfunction in adults after cardiac surgery with cardiopulmonary bypass: clinical significance and implications for practice. Am J Crit Care. 2004;13(5):384–393.
26. Maggart M, Stewart S. The mechanisms and management of noncardiogenic pulmonary edema following cardiopulmonary bypass. Ann Thorac Surg. 1987;43(2): 231–236.
27. Boyd JE, Bewman JH, Brigham KL. Permeability pulmonary edema. Diagnosis and management. Arch Intern Med. 1984;144(1):143–147.
28. Tonz M, et al. Acute lung injury during cardiopulmonary bypass. Are the neutrophils responsible? Chest. 1995;108(6):1551–1556.
29. Chenoweth DE, et al. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med. 1981;304(9): 497–503.
30. Royston D, et al. Increased production of peroxidation products associated with cardiac operations. Evidence for free radical generation. J Thorac Cardiovasc Surg. 1986;91(5):759–766.
31. Craddock PR, et al. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med. 1977;296(14):769–774.
32. Hammerschmidt DE, et al. Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1981;81(3):370–377.
33. Allardyce DB, Yoshida SH, Ashmore PG. The importance of microembolism in the pathogenesis of organ dysfunction caused by prolonged use of the pump oxygenator. J Thorac Cardiovasc Surg. 1966;52(5):706–715.
34. Heidecker J, Sahn SA. The spectrum of pleural effusions after coronary artery bypass grafting surgery. Clin Chest Med. 2006;27(2):267–283.
35. Peng MJ, et al. Postoperative pleural changes after coronary revascularization. Comparison between saphenous vein and internal mammary artery grafting. Chest. 1992;101(2):327–330.
36. Gale GD, et al. Pulmonary atelectasis and other respiratory complications after cardiopulmonary bypass and investigation of aetiological factors. Can Anaesth Soc J. 1979;26(1):15–21.
37. Daganou M, et al. Respiratory complications after coronary artery bypass surgery with unilateral or bilateral internal mammary artery grafting. Chest. 1998;113(5): 1285–1289.
38. Hurlbut D, et al. Pleuropulmonary morbidity: internal thoracic artery versus saphenous vein graft. Ann Thorac Surg. 1990;50(6):959–964.
39. Rolla G, et al. Effect of pleurotomy on pulmonary function after coronary artery bypass grafting with internal mammary artery. Respir Med. 1994;88(6):417–420.
40. Labidi M, et al. Pleural effusions following cardiac surgery. Prevalence, risk factors, and clinical features. Chest. 2009;136:1604–1611.
41. Peng MC, et al. Prevalence of symptomatic large pleural effusions first diagnosed more than 30 days after coronary artery bypass graft surgery. Respirology. 2007;12(1): 122–126.
42. Hashim SW, et al. Noncardiogenic pulmonary edema after cardiopulmonary bypass. An anaphylactic reaction to fresh frozen plasma. Am J Surg. 1984;147(4):560–564.
43. Brooks JC. Noncardiogenic pulmonary edema immediately following rapid
protamine administration.
Ann Pharmacother. 1999;33(9):927–930.
44. Frost L, et al. Prognosis and risk factors in acute, dialysis-requiring renal failure after open-heart surgery. Scand J Thorac Cardiovasc Surg. 1991;25(3):161–166.
45. MaWhinney S, et al. Identification of risk factors for increased cost, charges, and length of stay for cardiac patients. Ann Thorac Surg. 2000;70(3):702–710.
46. Suen WS, et al. Risk factors for development of acute renal failure (ARF) requiring dialysis in patients undergoing cardiac surgery. Angiology. 1998;49(10):789–800.
47. Lassnigg A, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15(6):1597–1605.
48. Swaminathan M, et al. Trends in acute renal failure associated with coronary artery bypass graft surgery in the United States. Crit Care Med. 2007;35(10):2286–2291.
49. Feindt PR, et al. Effects of high-dose aprotinin on renal function in aortocoronary bypass grafting. Ann Thorac Surg. 1995;60(4):1076–1080.
50. Kuitunen A, et al. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg. 2006;81(2):542–546.
51. Bellomo R, et al. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204–R212.
52. Hoste EA, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006;10(3):R73.
53. Bove T, et al. Renoprotective action of
fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial.
Circulation. 2005;111(24):3230–3235.
54. Sisillo E, et al. N-Acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial. Crit Care Med. 2008;36(1):81–86.
55. Barr LF, Kolodner K.
N-Acetylcysteine and
fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery.
Crit Care Med. 2008;36(5):1427–1435.
56. Ryckwaert F, et al. Incidence, risk factors, and prognosis of a moderate increase in plasma creatinine early after cardiac surgery. Crit Care Med. 2002;30(7):1495–1498.
57. Callahan M, et al. Economic consequences of renal dysfunction among cardiopulmonary bypass surgery patients: a hospital-based perspective. Value Health. 2003;6(2):137–143.
58. Rocktaeschel J, et al. Acid–base status of critically ill patients with acute renal failure: analysis based on Stewart–Figge methodology. Crit Care. 2003;7(4):R60.
59. Kellum JA, Song M, Li J. Lactic and hydrochloric acids induce different patterns of inflammatory response in LPS-stimulated RAW 264.7 cells. Am J Physiol Regul Integr Comp Physiol. 2004;286(4):R686–R692.
60. Thakar CV, et al. Renal dysfunction and serious infections after open-heart surgery. Kidney Int. 2003;64(1): 239–246.
61. Kramer AA, et al. Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. Kidney Int. 1999;55(6):2362–2367.
62. Donnahoo KK, et al. Review article: the role of tumor necrosis factor in renal ischemia–reperfusion injury. J Urol. 1999;162(1):196–203.
63. Egleston CV, et al. Gastrointestinal complications after cardiac surgery. Ann R Coll Surg Engl. 1993;75(1):52–56.
64. Mangi AA, et al. Gastrointestinal complications in patients undergoing heart operation: an analysis of 8709 consecutive cardiac surgical patients. Ann Surg. 2005;241(6):895–901. Discussion 901–904.
65. Ohri SK, et al. Intraabdominal complications after cardiopulmonary bypass. Ann Thorac Surg. 1991;52(4): 826–831.
66. Krasna MJ, et al. Gastrointestinal complications after cardiac surgery. Surgery. 1988;104(4):773–780.
67. Leitman IM, et al. Intra-abdominal complications of cardiopulmonary bypass operations. Surg Gynecol Obstet. 1987;165(3):251–254.
68. Lazar HL, et al. Gastrointestinal complications following cardiac surgery. Cardiovasc Surg. 1995;3(3):341–344.
69. Zacharias A, et al. Predictors of gastrointestinal complications in cardiac surgery. Tex Heart Inst J. 2000;27(2): 93–99.
70. Yilmaz AT, et al. Gastrointestinal complications after cardiac surgery. Eur J Cardiothorac Surg. 1996;10(9): 763–767.
71. Johnston G, et al. Changing perspective on gastrointestinal complications in patients undergoing cardiac surgery. Am J Surg. 1992;163(5):525–529.
72. Christenson JT, et al. Postoperative visceral hypotension the common cause for gastrointestinal complications after cardiac surgery. Thorac Cardiovasc Surg. 1994;42(3):152–157.
73. Baue AE. The role of the gut in the development of multiple organ dysfunction in cardiothoracic patients. Ann Thorac Surg. 1993;55(4):822–829.
74. Berger MM, et al. Intestinal absorption in patients after cardiac surgery. Crit Care Med. 2000;28(7):2217–2223.
75. Arrowsmith JE, Grocott HP, Newman MF. Neurologic risk assessment, monitoring and outcome in cardiac surgery. J Cardiothorac Vasc Anesth. 1999;13(6):736–743.
76. Svensson LG, Nadolny EM, Kimmel WA. Multimodal protocol influence on stroke and neurocognitive deficit prevention after ascending/arch aortic operations. Ann Thorac Surg. 2002;74(6):2040–2046.
77. Hogue CW Jr, et al. Sex differences in neurological outcomes and mortality after cardiac surgery: a Society of Thoracic Surgery National Database report. Circulation. 2001;103(17):2133–2137.
78. Roach GW, et al. Adverse cerebral outcomes after coronary bypass surgery. Multicenter study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med. 1996;335(25):1857–1863.
79. Grega MA, Borowicz LM, Baumgartner WA. Impact of single clamp versus double clamp technique on neurologic outcome. Ann Thorac Surg. 2003;75(5):1387–1391.
80. Hammon JW, et al. Single crossclamp improves 6-month cognitive outcome in high-risk coronary bypass patients: the effect of reduced aortic manipulation. J Thorac Cardiovasc Surg. 2006;131(1):114–121.
81. Kolkka R, Hilberman M. Neurologic dysfunction following cardiac operation with low-flow, low-pressure cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1980;79(3):432–437.
82. Cohn LH, Edmunds LH. Cardiac Surgery in the Adult. 3rd ed. New York: McGraw-Hill Medical; 2008:xx, 1704 pp.
83. Boeken U, et al. Neurological complications after cardiac surgery: risk factors and correlation to the surgical procedure. Thorac Cardiovasc Surg. 2005;53(1):33–36.
84. Selnes OA, et al. Cognitive changes with coronary artery disease: a prospective study of coronary artery bypass graft patients and nonsurgical controls. Ann Thorac Surg. 2003;75(5):1377–1384. Discussion 1384–1386.
85. Selnes OA, et al. Cognitive outcomes three years after coronary artery bypass surgery: a comparison of on-pump coronary artery bypass graft surgery and nonsurgical controls. Ann Thorac Surg. 2005;79(4): 1201–1209.
86. Jensen BO, et al. Cognitive outcomes in elderly high-risk patients after off-pump versus conventional coronary artery bypass grafting: a randomized trial. Circulation. 2006;113(24):2790–2795.
87. Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract. 2004;10 (suppl 2):46–52.
88. Goldberg PA, et al. Improving glycemic control in the cardiothoracic intensive care unit: clinical experience in two hospital settings. J Cardiothorac Vasc Anesth. 2004;18(6):690–697.
89. van den Berghe G, et al. Intensive
insulin therapy in the critically ill patients.
N Engl J Med. 2001;345(19): 1359–1367.
90. Arabi YM, et al. Intensive versus conventional
insulin therapy: a randomized controlled trial in medical and surgical critically ill patients.
Crit Care Med. 2008;36(12):3190–3197.
91. Arabi YM, Tamim HM, Rishu AH. Hypoglycemia with intensive
insulin therapy in critically ill patients: predisposing factors and association with mortality.
Crit Care Med. 2009;37(9):2536–2544.
92. Finfer S, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–1297.